Mark E. McDonnell

Mark E. McDonnell

Auto-generated profile, based on publicly available information

Mark E. McDonnell

Fox Chase Therapeutics Discovery, Inc., 3805 Old Easton Road, Doylestown, Pennsylvania 18902, United States

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
TMTroy E. Messick
Troy E. Messick
GSGarry R. Smith
Garry R. Smith
SSSamantha S. Soldan
Samantha S. Soldan
MMMark E. McDonnell
Mark E. McDonnell
JDJulianna S. Deakyne
Julianna S. Deakyne
PLPaul Lieberman
Paul Lieberman
EBNA1 inhibitors developed by fragment-based drug design block EBNA1 DNA binding and EBV-dependent tumor cell growth in vivo.

8 October 1999 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DBDerek Brundish
Derek Brundish
ABAlice Bull
Alice Bull
VDVera Donovan
Vera Donovan
JFJoseph D. Fullerton
Joseph D. Fullerton
SGSheila M. Garman
Sheila M. Garman
MTMark D. Talbot
Mark D. Talbot

18 January 2023 in Tetrahedron Letters
Verified
Journal Article
Closed access
WKWilliam A. Kinney
William A. Kinney
MMMark E. McDonnell
Mark E. McDonnell
SFStanley Freeman
Stanley Freeman
NSNick Simons
Nick Simons
CHChao Han
Chao Han
LYLanyi Yang
Lanyi Yang

27 November 2014
Verified
Book Chapter
Closed access
PDF file
MMMark McDonnell
Mark McDonnell

11 June 2026 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
GSGarry R. Smith
Garry R. Smith
MMMark E. McDonnell
Mark E. McDonnell
YZYan Zhang
Yan Zhang
VVVenkata Velvadapu
Venkata Velvadapu
SCShuai Chen
Shuai Chen
TMTroy E. Messick
Troy E. Messick